Noninvasive measures of cardiovascular changes in diabetes mellitus

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 14, Issue 4, 2007, Pages 263-268

  Wadwa, R Paul ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Cardiovascular disease; Coronary artery disease; Diabetes mellitus; Noninvasive detection

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIMEPIRIDE; HIGH DENSITY LIPOPROTEIN; PIOGLITAZONE; PLACEBO; TETRAHYDROLIPSTATIN; TROGLITAZONE;

ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DYSLIPIDEMIA; ELECTROCARDIOGRAM; ELECTRON BEAM TOMOGRAPHY; EXERCISE TEST; GENETIC MARKER; HEART MUSCLE PERFUSION; HOLTER MONITORING; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PEDIATRICS; PULSE WAVE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; STRESS ECHOCARDIOGRAPHY;

EID: 34447578772     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32825a674d     Document Type: Review

References (48)

1. Devine PJ, Carlson DW, Taylor AJ. Clinical value of carotid intima-media thickness testing. J Nucl Cardiol 2006; 13:710-718. An excellent discussion of the technique of measuring cIMT and potential uses is presented here.
2. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006; 23:609-616. This meta-analysis reviews a large amount of cIMT data in studies from around the world including T2DM patients from several different ethnic groups.
3. Hodis HN, Mack WJ, Zheng L, et al. Effect of peroxisome proliferator-activated receptor γ agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. Diabetes Care 2006; 29:1545-1553. A well-written and well-executed study of the effect of TZD therapy on cIMT in a mostly Hispanic group of T2DM patients from a group with expertise in measuring cIMT.
4. Mazzone T, Meyer PM, Feinstein SB, et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 2006; 296:2572-2581. This study of thiazolidinedione effect on cIMT includes a larger cohort of mostly non-Hispanic white subjects with T2DM (also a well-executed trial).
5. Krantz JS, Mack WJ, Hodis HN, et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 2004; 145:452-457.
6. Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109:1750-1755.
7. Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006; 74:33-40. This study documents vascular changes seen in T1DM as early as adolescence with a comparison to nondiabetic youth.
8. Atabek ME, Pirgon O, Kurtoglu S, Imamoglu H. Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood. Pediatr Cardiol 2006; 27:428-433.
9. Hedblad B, Zambanini A, Nilsson P, et al. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. J Intern Med 2007; 261:293-305.
10. Kim SH, Lee SJ, Kang ES, et al. Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 2006; 55:1053-1059. This intervention study documents the potential that lifestyle modification can have on the vasculature. It also demonstrates that differences in cIMT with such intervention may be seen in a 6-month time period.
11. Burdon KP, Langefeld CD, Wagenknecht LE, et al. Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with type 2 diabetes mellitus: the Diabetes Heart Study. Diabet Med 2006; 23:228-234.
12. Burdon KP, Langefeld CD, Beck SR, et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J 2006; 151:706-711. This paper includes interesting data from the Diabetes Heart Study examining single nucleotide polymorphisms in the CD40 and CD40 ligand genes, and potential associations with cIMT and coronary artery calcification.
13. Burdon KP, Bento JL, Langefeld CD, et al. Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the Diabetes Heart Study. Diabetes 2006; 55:651-658.
14. 2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 2007; 92:345-352.
15. Liu Y, Herrington D, Burdon KP, et al. A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study. Eur J Cardiovasc Prev Rehabil 2006; 13:655-657.
16. Yamasaki Y, Katakami N, Sakamoto K, et al. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care 2006; 29:2445-2451. The timely article documents the investigators approach to evaluating combinations of single nucleotide polymorphisms associated with CVD.
17. Distiller LA, Joffe BI, Melville V, et al. Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus. J Diabetes Complications 2006; 20:280-284. An interesting evaluation of known CVD risk factors affecting cIMT in patients with T1DM for over 18 years.
18. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient-Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006; 98 (2A):2H-15H. A thought provoking statement from the Screening for Heart Attack Prevention and Education task force with recommendations for screening in those at highest risk for CVD with the goal of decreasing the incidence of cardiovascular morbidity and mortality in the US.
19. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl 1996; 14:S147-S157.
20. Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with type 2 diabetes and cardiovascular disease. Diabetes Care 2004; 27:746-751.
21. Lacy PS, O'Brien DG, Stanley AG, et al. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004; 22:1937-1944.
22. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605. This is an excellent review of various arterial stiffness measurement techniques. The paper reviews data on several of the newest technologies being used.
23. Vlachopoulos C, Aznaouridis K, Stefanadis C. Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart 2006; 92:1544-1550. A more concise review of the utility of measuring arterial stiffness in the clinical setting.
24. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225. This study utilized PWA to document vascular changes with antihypertensive medications in a relatively large study.
25. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670. This study is an important evaluation of PWV as a tool to assess risk for CVD events in patients with and without diabetes. The paper provides evidence for use of PWV measurement in the clinical setting.
26. Barinas-Mitchell E, Kuller LH, Sutton-Tyrrell K, et al. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Diabetes Care 2006; 29:2218-2222. A well-written paper documenting vascular changes seen in T2DM patients achieving weight loss. The paper documents PWV changes that may be seen after 1 year of intervention.
27. Hatsuda S, Shoji T, Shinohara K, et al. Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb 2006; 13:114-121. This paper illustrates vascular differences in T2DM patients with ischemic heart disease that may be detected using the Colin instrument.
28. Kimoto E, Shoji T, Shinohara K, et al. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease. J Am Soc Nephrol 2006; 17:2245-2252.
29. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48:80-86.
30. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109:184-189.
31. Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 2004; 27:2911-2917.
32. Urbina EM, Kieltkya L, Tsai J, et al. Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: the Bogalusa Heart Study. Am J Hypertens 2005; 18:767-771.
33. Budoff MJ, Flores F, Tsai J, et al. Measures of brachial artery distensibility in relation to coronary calcification. Am J Hypertens 2003; 16 (5 Pt 1):350-355.
34. Cleary PA, Orchard TJ, Genuth S, et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 2006; 55:3556-3565. An outstanding paper from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study documenting differences seen in coronary calcification related to glycemic control during the Diabetes Control and Complications Trial.
35. Snell-Bergeon JK, Hokanson JE, Jensen L, et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 2003; 26:2923-2928.
36. Dabelea D, Kinney G, Snell-Bergeon JK, et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003; 52:2833-2839.
37. Starkman HS, Cable G, Hala V, et al. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care 2003; 26:433-436.
38. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006; 114:1761-1791. This is an important scientific statement from the American Heart Association discussing the techniques of assessing coronary plaque using computed tomography.
39. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007; 115:402-426. An important statement from the American College of Cardiology and the American Heart Association with a focus on the clinical aspects of evaluating coronary calcium.
40. Kretowski A, Hokanson JE, McFann K, et al. The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes. Diabetologia 2006; 49:1946-1954. This analysis illustrates the potential for identifying genetic markers associated with increased risk for coronary disease.
41. Kretowski A, McFann K, Hokanson JE, et al. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 2007; 56:863-871. Also an interesting analysis identifying genetic markers with potential for identifying those individuals at increased risk for coronary disease.
42. Wadwa RP, Kinney GL, Ogden L, et al. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 2006; 38:996-1003. A case-control study identifying markers that should be studied further as candidates to identify patients at increased risk for coronary artery disease.
43. Wagenknecht LE, Langefeld CD, Carr JJ, et al. Race-specific relationships between coronary and carotid artery calcification and carotid intimal medial thickness. Stroke 2004; 35:e97-e99.
44. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345:1863-1869.
45. Kim WY, Astrup AS, Stuber M, et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 2007; 115:228-235. An interesting study of coronary and aortic plaque burden in T1DM subjects with and without nephropathy, illustrating the use of cardiovascular MRI.
46. Sirineni GK, Stillman AE. Understanding the heart: CT and MRI for coronary heart disease. J Thorac Imaging 2007; 22:107-113. An excellent review that includes an important section on the use of MRI to evaluate the coronary arteries.
47. American Diabetes Association. Consensus Development Conference on the Diagnosis of Coronary Heart Disease In People With Diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998; 21:1551-1559.
48. Bax JJ, Inzucchi SE, Bonow RO, et al. Cardiac imaging for risk stratification in diabetes. Diabetes Care 2007; 30:1295-1304. An excellent review of the data on cardiac imaging and how it may be applied in the clinical setting in the care of diabetes patients.